Alternatively, the observed downregulation of pSTAT3 in high-IGF2BP1 tumors may reflect compensatory mechanisms or shifts in immune signaling dynamics unique to the endometrial tumor microenvironment. Here, IGF2BP1 is linked to endometrium neoplasm.